GLI-2 Antibodies

Santa Cruz Biotechnology provides a broad selection of GLI-2 monoclonal antibodies for research focused on understanding GLI-2 protein function. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GLI-2 is a key transcription factor in the Hedgehog signaling pathway, which is crucial for regulating cell growth, differentiation, and tissue patterning during embryonic development. Aberrant GLI-2 activity has been implicated in various cancers and developmental disorders, making it an important target for therapeutic intervention. Understanding the function and regulation of GLI-2 can provide insights into the mechanisms underlying these diseases. GLI-2 monoclonal antibodies enable detailed investigation of protein expression patterns across different tissues and cellular compartments. Researchers can utilize GLI-2 monoclonal antibodies to examine protein-protein interactions and post-translational modifications that regulate GLI-2 activity. Advanced research techniques incorporating GLI-2 monoclonal antibodies help reveal new therapeutic targets in cancer biology and developmental disorders. Santa Cruz Biotechnology monoclonal antibodies for GLI-2 support researchers worldwide in advancing our understanding of critical cellular pathways and disease mechanisms.